Salix

Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra
Salix, US WorldMeds eye 2019 push into the mainstream for opioid withdrawal drug Lucemyra
Fierce Pharma
Salix
US WorldMeds
physicians
opioids
opioid withdrawal
Lucemyra
Flag link:
Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra
Valeant signs with WorldMeds to hawk first-ever opioid withdrawal drug Lucemyra
Fierce Pharma
US WorldMeds
FDA
Lucemyra
opioid withdrawal
Valeant Pharmaceuticals
Salix
Flag link:
Debt-laden Valeant goes deeper in the hole with $200M-plus Salix settlement
Debt-laden Valeant goes deeper in the hole with $200M-plus Salix settlement
Fierce Pharma
Valeant Pharmaceuticals
Salix
Flag link:
Valeant touts Salix salesforce scale-up amid rumors of mass rep exit
Valeant touts Salix salesforce scale-up amid rumors of mass rep exit
Fierce Pharma
Valeant Pharmaceuticals
Salix
drug reps
hirings
Flag link:
Will Takeda Buy Salix?
Will Takeda Buy Salix?
Seeking Alpha
Takeda
Salix
M&A
Flag link:
Valeant: The Salix Sale Debacle
Valeant: The Salix Sale Debacle
Seeking Alpha
Valeant Pharmaceuticals
Salix
M&A
Takeda
Flag link:
Valeant: Don't WrIte Off Salix's Sale Potential
Valeant: Don't WrIte Off Salix's Sale Potential
Seeking Alpha
Valeant Pharmaceuticals
hirings
Salix
Takeda
M&A
Flag link:
Should Valeant Shareholders Be Content With The Firesale Beginning?
Should Valeant Shareholders Be Content With The Firesale Beginning?
Seeking Alpha
Valeant Pharmaceuticals
M&A
Salix
Flag link:
What would a Salix sale do for Valeant?
What would a Salix sale do for Valeant?
BioPharma Dive
Salix
Valeant Pharmaceutcals
M&A
Flag link:
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Valeant in talks to sell Salix stomach-drug unit in $10 billion deal
Reuters
Valeant Pharmaceuticals
Salix
M&A
Takeda
Flag link:
Valeant settles Salix drug probe for $54M
Valeant settles Salix drug probe for $54M
BioPharma Dive
Valeant Pharmaceuticals
Salix
Flag link:
Valeant's prized GI force, once shielded from job cuts, faces the ax
Valeant's prized GI force, once shielded from job cuts, faces the ax
Fierce Pharma Marketing
Valeant Pharmaceuticals
layoffs
Salix
Flag link:
Valeant's latest tax-cutting tactic, courtesy of Luxembourg
Valeant's latest tax-cutting tactic, courtesy of Luxembourg
Fierce Pharma
Valeant Pharmaceuticals
Luxembourg
Salix
Flag link:
Raleigh's BioDelivery hires former Salix sales workers
Raleigh's BioDelivery hires former Salix sales workers
Bizjournals.com
BioDelivery Sciences
Salix
hirings
Flag link:
Valeant chief latest pharma CEO to question M&A mania, calls it a 'bit of a bubble'
Valeant chief latest pharma CEO to question M&A mania, calls it a 'bit of a bubble'
BioPharma Dive
Valeant Pharmaceuticals
M&A
Pharma CEOs
J. Michael Pearson
Salix
Flag link:
Valeant starts $500M in Salix cost-cutting with 250 layoffs
Valeant starts $500M in Salix cost-cutting with 250 layoffs
Fierce Pharma
Valeant Pharmaceuticals
Salix
layoffs
M&A
Flag link:
Why Valeant Had to Increase Salix Bid…and Endo Had to Walk Away
Why Valeant Had to Increase Salix Bid…and Endo Had to Walk Away
Barron's
Salix
M&A
Valeant Pharmaceuticals
Endo Health Solutions
Flag link:
Valeant successfully fends off Endo, seals deal with Salix
Valeant successfully fends off Endo, seals deal with Salix
BioPharma Dive
Valeant Pharmaceuticals
Salix
Endo Health Solutions
M&A
Flag link:
Sorry, Endo. Valeant's back on top with $173-per-share Salix bid
Sorry, Endo. Valeant's back on top with $173-per-share Salix bid
Fierce Pharma
Endo Health Solutions
Valeant Pharmaceuticals
Salix
M&A
Flag link:
Endo claims it could close Salix deal swiftly
Endo claims it could close Salix deal swiftly
Yahoo/Reuters
Salix
Endo Health Solutions
Valeant Pharmaceuticals
M&A
Flag link:

Pages